Effectiveness of the Acute Respiratory Infection Smart Form - Full Text View

Sponsored by:	Agency for Healthcare Research and Quality (AHRQ)
Information provided by:	Agency for Healthcare Research and Quality (AHRQ)
ClinicalTrials.gov Identifier:	NCT00235040

Purpose

To evaluate the effectiveness of the Acute Respiratory Infection Smart Form

Condition	Intervention
Respiratory Tract Infections	Behavioral: Antibiotic prescribing rates

MedlinePlus related topics: Antibiotics

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment
Official Title:	Evaluating Smart Forms and Quality Dashboards in an EHR: Effectiveness of the Acute Respiratory Infection Smart Form

Further study details as provided by Agency for Healthcare Research and Quality (AHRQ):

Primary Outcome Measures:

Antibiotic prescribing rates

Secondary Outcome Measures:

Appropriateness of antibiotic prescribing, re-visit rates, antibiotic costs, use of antibiotics, all-cause antibiotic use, quality of documentation

Estimated Enrollment:	20000
Study Start Date:	November 2005
Estimated Study Completion Date:	August 2007

Detailed Description:

Specific Aim 1: To design and implement an integrated documentation-based clinical decision support and physician feedback system, provided in an electronic health record (EHR), to improve the management of patients with acute medical conditions.

Hypothesis 1: A documentation-based clinical decision support tool (CDSS) “smart form” physician feedback system, can be designed and implemented to facilitate documentation and physician order-entry, provide individualized, evidence-based recommendations for the management of patients acute respiratory infections (ARIs), and are usable by primary care physicians.

Specific Aim 2: To determine the effectiveness of documentation-based CDSS and physician feedback on documentation and the clinical management of patients respiratory tract infections.

Hypothesis 2A: A documentation-based CDSS “smart form” will increase the documentation of important clinical data in patients with ARI when compared to usual practice.

Hypothesis 2B: A documentation-based CDSS “smart form” will increase adherence with guidelines for the management of patients with ARI when compared to usual practice.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

All patients of physicians participating in the study

Exclusion Criteria:

Any patients who are not part of a panel of a participating physician

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00235040

Contacts

Contact: Lana Tsurikova, MA		rtsurikova@partneras.org
Contact: Jeffrey A. Linder, MD, MPH		jlinder@partners.org

Sponsors and Collaborators

Agency for Healthcare Research and Quality (AHRQ)

Investigators

Principal Investigator:

Blackford Middleton, MD, MPH, MSc

Partners Healthcare Systems Inc

More Information

Study ID Numbers:	R01HS015169-1, R01 HS015169
Study First Received:	October 6, 2005
Last Updated:	October 7, 2005
ClinicalTrials.gov Identifier:	NCT00235040
Health Authority:	United States: Federal Government

Keywords provided by Agency for Healthcare Research and Quality (AHRQ):

Upper Respiratory Infections
Respiratory Tract Infections
Tree Number C01.539.739
Tree Number C08.730
Unique ID D012141

Study placed in the following topic categories:

Respiratory Tract Diseases
Respiratory Tract Infections

Additional relevant MeSH terms:

Communicable Diseases
Infection

ClinicalTrials.gov processed this record on January 16, 2009